DGX — Quest Diagnostics
Health Care|Health Care Services
4 Articles
DGXEarningspositive
Quest Diagnostics Beats Q1 Estimates with $2.50 EPS, Raises Full-Year Guidance
Quest Diagnostics reported Q1 2026 adjusted EPS of $2.50, beating estimates, with 9.2% revenue growth to $2.90 billion. The company raised full-year guidance citing strong demand.
4 min read
DGXLeadershippositive
Quest Diagnostics Adds Former Walgreens CEO Tim Wentworth to Board
Quest Diagnostics elected Timothy Wentworth, former CEO of Walgreens Boots Alliance, as independent director, appointing him to compensation and quality committees.
3 min read
DGXEarningspositive
Quest Diagnostics Hikes Dividend 7.5% After $8.75 EPS in 2025
Quest Diagnostics raised its quarterly dividend to $0.86 and authorized $1B in buybacks following full-year 2025 EPS of $8.75 on net income of $990 million.
3 min read
DGXInsider Tradingneutral
Quest Diagnostics Executives Receive $6.3 Million in Stock Awards
Eight Quest Diagnostics insiders received stock awards totaling 30,436 shares worth $6.3 million at current prices, with several executives immediately selling portions.
3 min read